173 related articles for article (PubMed ID: 24295813)
1. Fast-channel congenital myasthenic syndrome with a novel acetylcholine receptor mutation at the α-ε subunit interface.
Webster R; Liu WW; Chaouch A; Lochmüller H; Beeson D
Neuromuscul Disord; 2014 Feb; 24(2):143-7. PubMed ID: 24295813
[TBL] [Abstract][Full Text] [Related]
2. A novel congenital myasthenic syndrome due to decreased acetylcholine receptor ion-channel conductance.
Webster R; Maxwell S; Spearman H; Tai K; Beckstein O; Sansom M; Beeson D
Brain; 2012 Apr; 135(Pt 4):1070-80. PubMed ID: 22382357
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic diversity underlying fast channel congenital myasthenic syndromes.
Sine SM; Wang HL; Ohno K; Shen XM; Lee WY; Engel AG
Ann N Y Acad Sci; 2003 Sep; 998():128-37. PubMed ID: 14592870
[TBL] [Abstract][Full Text] [Related]
4. Congenital myasthenic syndrome caused by low-expressor fast-channel AChR delta subunit mutation.
Shen XM; Ohno K; Fukudome T; Tsujino A; Brengman JM; De Vivo DC; Packer RJ; Engel AG
Neurology; 2002 Dec; 59(12):1881-8. PubMed ID: 12499478
[TBL] [Abstract][Full Text] [Related]
5. Mutation in the AChR ion channel gate underlies a fast channel congenital myasthenic syndrome.
Webster R; Brydson M; Croxen R; Newsom-Davis J; Vincent A; Beeson D
Neurology; 2004 Apr; 62(7):1090-6. PubMed ID: 15079006
[TBL] [Abstract][Full Text] [Related]
6. Congenital myasthenic syndrome in Japan: ethnically unique mutations in muscle nicotinic acetylcholine receptor subunits.
Azuma Y; Nakata T; Tanaka M; Shen XM; Ito M; Iwata S; Okuno T; Nomura Y; Ando N; Ishigaki K; Ohkawara B; Masuda A; Natsume J; Kojima S; Sokabe M; Ohno K
Neuromuscul Disord; 2015 Jan; 25(1):60-9. PubMed ID: 25264167
[TBL] [Abstract][Full Text] [Related]
7. Novel delta subunit mutation in slow-channel syndrome causes severe weakness by novel mechanisms.
Gomez CM; Maselli RA; Vohra BP; Navedo M; Stiles JR; Charnet P; Schott K; Rojas L; Keesey J; Verity A; Wollmann RW; Lasalde-Dominicci J
Ann Neurol; 2002 Jan; 51(1):102-12. PubMed ID: 11782989
[TBL] [Abstract][Full Text] [Related]
8. Investigation of Congenital Myasthenia Reveals Functional Asymmetry of Invariant Acetylcholine Receptor (AChR) Cys-loop Aspartates.
Shen XM; Brengman J; Neubauer D; Sine SM; Engel AG
J Biol Chem; 2016 Feb; 291(7):3291-301. PubMed ID: 26698174
[TBL] [Abstract][Full Text] [Related]
9. A novel fast-channel myasthenia caused by mutation in β subunit of AChR reveals subunit-specific contribution of the intracellular M1-M2 linker to channel gating.
Shen XM; Di L; Shen S; Zhao Y; Neumeyer AM; Selcen D; Sine SM; Engel AG
Exp Neurol; 2020 Sep; 331():113375. PubMed ID: 32504635
[TBL] [Abstract][Full Text] [Related]
10. Highly fatal fast-channel syndrome caused by AChR ε subunit mutation at the agonist binding site.
Shen XM; Brengman JM; Edvardson S; Sine SM; Engel AG
Neurology; 2012 Jul; 79(5):449-54. PubMed ID: 22592360
[TBL] [Abstract][Full Text] [Related]
11. Slow-Channel Congenital Myasthenic Syndrome due to a Novel Mutation in the Acetylcholine Receptor Alpha Subunit in a South Asian: A Case Report.
Gooneratne IK; Nandasiri S; Maxwell S; Webster R; Cossins J; Beeson D; Gunaratne K; Herath L; Senanayake S; Chang T
J Neuromuscul Dis; 2021; 8(1):163-167. PubMed ID: 33216040
[TBL] [Abstract][Full Text] [Related]
12. Mutation of single murine acetylcholine receptor subunits reveals differential contribution of P121 to acetylcholine binding and channel opening.
Peter C; Korngreen A; Witzemann V
Pflugers Arch; 2005 Jun; 450(3):178-84. PubMed ID: 15864502
[TBL] [Abstract][Full Text] [Related]
13. CHRND mutation causes a congenital myasthenic syndrome by impairing co-clustering of the acetylcholine receptor with rapsyn.
Müller JS; Baumeister SK; Schara U; Cossins J; Krause S; von der Hagen M; Huebner A; Webster R; Beeson D; Lochmüller H; Abicht A
Brain; 2006 Oct; 129(Pt 10):2784-93. PubMed ID: 16916845
[TBL] [Abstract][Full Text] [Related]
14. A Missense Mutation in Epsilon-subunit of Acetylcholine Receptor Causing Autosomal Dominant Slow-channel Congenital Myasthenic Syndrome in a Chinese Family.
Tan JZ; Man Y; Xiao F
Chin Med J (Engl); 2016 Nov; 129(21):2596-2602. PubMed ID: 27779167
[TBL] [Abstract][Full Text] [Related]
15. Myasthenic syndrome AChRα C-loop mutant disrupts initiation of channel gating.
Shen XM; Brengman JM; Sine SM; Engel AG
J Clin Invest; 2012 Jul; 122(7):2613-21. PubMed ID: 22728938
[TBL] [Abstract][Full Text] [Related]
16. Naturally occurring mutations at the acetylcholine receptor binding site independently alter ACh binding and channel gating.
Sine SM; Shen XM; Wang HL; Ohno K; Lee WY; Tsujino A; Brengmann J; Bren N; Vajsar J; Engel AG
J Gen Physiol; 2002 Oct; 120(4):483-96. PubMed ID: 12356851
[TBL] [Abstract][Full Text] [Related]
17. Clinical and neurophysiological response to ephedrine in a patient affected with slow-channel congenital myasthenic syndrome.
Eirís-Puñal J; Fuentes-Pita P; Gómez-Lado C; Pérez-Gay L; López-Vázquez A; Quintas-Rey R; Barros-Angueira F; Pardo J
Rev Neurol; 2020 Sep; 71(6):221-224. PubMed ID: 32895905
[TBL] [Abstract][Full Text] [Related]
18. Slow-channel mutation in acetylcholine receptor alphaM4 domain and its efficient knockdown.
Shen XM; Deymeer F; Sine SM; Engel AG
Ann Neurol; 2006 Jul; 60(1):128-36. PubMed ID: 16685696
[TBL] [Abstract][Full Text] [Related]
19. Rare slow channel congenital myasthenic syndromes without repetitive compound muscle action potential and dramatic response to low dose fluoxetine.
Durmus H; Sticht H; Ceylaner S; Hashemolhosseini S; Deymeer F
Acta Neurol Belg; 2021 Dec; 121(6):1755-1760. PubMed ID: 33030681
[TBL] [Abstract][Full Text] [Related]
20. [Congenital myasthenic syndromes: phenotypic expression and pathophysiological characterisation].
Andreux F; Hantaï D; Eymard B
Rev Neurol (Paris); 2004 Feb; 160(2):163-76. PubMed ID: 15034473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
